WallStreetZenWallStreetZen

NASDAQ: REPL
Replimune Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Replimune Group earnings were -$228.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest REPL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$66.3M, up 25% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, REPL reported annual earnings of -$215.8M, with 23.8% growth.

REPL earnings history

Current Revenue
$0.0
Current Earnings
-$228.2M
Current Profit Margin
0%

REPL Return on Equity

Current Company
-54.8%
Current Industry
-2%
Current Market
34.1%
REPL's Return on Equity (-54.8%)... subscribe to Premium to read more.
High Return on Equity Performance

REPL undefined

Current Company
-43%
Current Industry
-0.4%
REPL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when REPL announces earnings.

REPL undefined

Current Company
-39.56%
Current Industry
5.9%
REPL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

REPL vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
REPL-$216.52M-$228.24MN/A-$3.07
NUVB-$567.09M-$567.94MN/A-$2.11
AVBP-$80.49M-$80.49MN/A-$2.56
LENZ-$49.71M-$49.77MN/A-$2.34
BCAX-$67.83M-$68.00MN/A-$4.05
View Top Biotech Stocks

Replimune Group Earnings Reports & History FAQ

What were Replimune Group's earnings last quarter?

On REPL's earnings call on Invalid Date, Replimune Group (NASDAQ: REPL) reported Q4 2024 earnings per share (EPS) of -$0.79, up 2.6% year over year. Total REPL earnings for the quarter were -$66.34 million. In the same quarter last year, Replimune Group's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Replimune Group stock.

Is Replimune Group profitable or losing money?

As of the last Replimune Group earnings report, Replimune Group is currently losing money. Replimune Group's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$228.24 million, a 8.71% increase year over year.

What was REPL's earnings growth in the past year?

As of Replimune Group's earnings date in Invalid Date, Replimune Group's earnings has grown year over year. REPL earnings in the past year totalled -$228.24 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.